Search results for “myeloproliferative neoplasms”

Unusual cutaneous toxicity after prolonged use of Hydroxyurea in polycythemia vera: a case report

Hydroxyurea (HU) is commonly used for the long-term treatment of patients with chronic myeloproliferative neoplasms. The drug is usually well tolerated in the large majority of subjects, although systemic and/or localized toxicities have seldom been reported. Here we report a case of unusual cutaneous toxicity due long-term use of HU in a patient with polycythemia vera.